Trial Profile
A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental Stuttering
Status:
Suspended
Phase of Trial:
Phase III
Latest Information Update: 06 May 2022
Price :
$35
*
At a glance
- Drugs Asenapine (Primary)
- Indications Stuttering
- Focus Therapeutic Use
- 25 Apr 2015 New trial record